Genetic Variants Associated with Insulin Signaling and Glucose Homeostasis in the Pathogenesis of Insulin Resistance in Polycystic Ovary Syndrome: a Systematic Review

Overview

Journal J Assist Reprod Genet

Publisher Springer

Specialties Genetics
Reproductive Medicine

Date 2013 Jun 25

PMID 23794114

Citations 10

Authors

Bhaskar Venkata Kameswara Subrahmanya Lakkakula

Maheswari Thangavelu

Usha Rani Godla

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovary syndrome must be recognized as a serious issue due to its implication on long term health regardless of an individual's age. PCOS and insulin resistance are interlinked, as approximately 40 % of women with PCOS are insulin resistant. However, the detailed molecular basis for insulin resistance that is coupled with PCOS remains poorly understood.

Objective: To review the published evidence that polymorphisms in genes that are involved in insulin secretion and action are associated with an increased risk of PCOS.

Methods: We reviewed articles published through November 2012 which concerned polymorphisms of genes related to insulin signaling and glucose homeostasis as well as their associations with PCOS. The articles were identified via Medline searches.

Conclusions: No consistent evidence emerged of a strong association between the risk of PCOS and any known gene that is related to insulin signaling and glucose homeostasis. Moreover, recent genome-wide association studies are inconsistent in identifying the associations between PCOS and insulin metabolism genes. Many of the studies reviewed were limited by heterogeneity in the PCOS diagnosis and by not have having a sufficient number of study participants. Further studies are warranted to determine predisposing risk factors which could modify environmental factors and thus reduce the risk of PCOS. Large genome-wide association studies devoted solely to PCOS will be necessary to identify new candidate genes and proteins that are involved in PCOS risk.

Citing Articles

Relationship between polycystic ovary syndrome and high periostin level.

Eroglu S, Cakmakliogullari E Rev Assoc Med Bras (1992). 2024; 70(6):e20240138.

PMID: 39045965 PMC: 11288256. DOI: 10.1590/1806-9282.20240138.

Comparative effects of acupuncture and metformin on insulin sensitivity in overweight/obese and lean women with polycystic ovary syndrome and insulin resistance: a analysis of a randomized trial.

Cao J, Nie G, Dai Z, Shan D, Wei Z Front Med (Lausanne). 2023; 10:1232127.

PMID: 38155665 PMC: 10753002. DOI: 10.3389/fmed.2023.1232127.

Effect of Wenshentiaojing Decoction on Hormone Level and Follicular Number in Patients with Menstrual Disorder of Polycystic Ovary Syndrome.

Li L, Huang N, Qi Y, Li Y, Wang L Evid Based Complement Alternat Med. 2021; 2021:4975867.

PMID: 34880919 PMC: 8648443. DOI: 10.1155/2021/4975867.

The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome.

Zhang Y, Guo X, Ma S, Ma H, Li H, Wang Y Evid Based Complement Alternat Med. 2021; 2021:6678398.

PMID: 34055020 PMC: 8149243. DOI: 10.1155/2021/6678398.

Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway .

Zhou J, Tan Y, Wang X, Zhu M Aging (Albany NY). 2021; 13(5):7084-7095.

PMID: 33638949 PMC: 7993663. DOI: 10.18632/aging.202564.

References

Sawathiparnich P, Weerakulwattana L, Santiprabhob J, Likitmaskul S . Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS. J Med Assoc Thai. 2006; 88 Suppl 8:S33-7. View

Kolodziejczyk B, Duleba A, Spaczynski R, Pawelczyk L . Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril. 2000; 73(6):1149-54. DOI: 10.1016/s0015-0282(00)00501-x. View

Chen Z, Zhao H, He L, Shi Y, Qin Y, Shi Y . Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2010; 43(1):55-9. DOI: 10.1038/ng.732. View

Lee J, Lee W, Hur S, Lee C, Sung Y, Chung H . 111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women. Fertil Steril. 2008; 92(2):830-3. DOI: 10.1016/j.fertnstert.2008.06.023. View

Lin T, Yen J, Gong K, Kuo T, Ku D, Liang S . Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism. BMC Med Genet. 2006; 7:36. PMC: 1481546. DOI: 10.1186/1471-2350-7-36. View

Antoine H, Pall M, Trader B, Chen Y, Azziz R, Goodarzi M . Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril. 2006; 87(4):862-9. PMC: 1925257. DOI: 10.1016/j.fertnstert.2006.10.006. View

Ehrmann D, Tang X, Yoshiuchi I, Cox N, Bell G . Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87(9):4297-300. DOI: 10.1210/jc.2002-020216. View

Huang W, Liu J, Li L . [Analysis of environmental factors and polycystic ovary syndrome]. Zhonghua Fu Chan Ke Za Zhi. 2007; 42(5):302-4. View

Colilla S, Cox N, Ehrmann D . Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab. 2001; 86(5):2027-31. DOI: 10.1210/jcem.86.5.7518. View

10.

Lucassen A, Julier C, Beressi J, Boitard C, Froguel P, Lathrop M . Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet. 1993; 4(3):305-10. DOI: 10.1038/ng0793-305. View

11.

ODell S, Day I . Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol. 1998; 30(7):767-71. DOI: 10.1016/s1357-2725(98)00048-x. View

12.

Hara M, Alcoser S, Qaadir A, Beiswenger K, Cox N, Ehrmann D . Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. J Clin Endocrinol Metab. 2002; 87(2):772-5. DOI: 10.1210/jcem.87.2.8255. View

13.

Escobar-Morreale H, Peral B, Villuendas G, Calvo R, Sancho J, San Millan J . Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil Steril. 2002; 77(3):581-7. DOI: 10.1016/s0015-0282(01)03206-x. View

14.

Nestler J, Jakubowicz D, Evans W, Pasquali R . Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998; 338(26):1876-80. DOI: 10.1056/NEJM199806253382603. View

15.

Ablooglu A, Frankel M, Rusinova E, Ross J, Kohanski R . Multiple activation loop conformations and their regulatory properties in the insulin receptor's kinase domain. J Biol Chem. 2001; 276(50):46933-40. DOI: 10.1074/jbc.M107236200. View

16.

Orio Jr F, Palomba S, Cascella T, Di Biase S, Labella D, Russo T . Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2004; 89(10):5110-5. DOI: 10.1210/jc.2004-0109. View

17.

Saltiel A, Kahn C . Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001; 414(6865):799-806. DOI: 10.1038/414799a. View

18.

Navaratnarajah R, C Pillay O, Hardiman P . Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med. 2008; 26(1):62-71. DOI: 10.1055/s-2007-992926. View

19.

Witchel S, Kahsar-Miller M, Aston C, White C, Azziz R . Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertil Steril. 2005; 83(2):371-5. DOI: 10.1016/j.fertnstert.2004.10.027. View

20.

Witchel S, Smith R, Tomboc M, Aston C . Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril. 2001; 75(4):724-30. DOI: 10.1016/s0015-0282(00)01798-2. View